Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Donnell, W. J.
Right arrow Articles by Lahive, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Donnell, W. J.
Right arrow Articles by Lahive, K. C.
(Chest. 1998;114:1264-1268.)
© 1998 American College of Chest Physicians

Clearance of Pneumocystis carinii Cysts in Acute P carinii Pneumonia

Assessment by Serial Sputum Induction

Walter J. O'Donnell MD, FCCP1; Walter Pieciak BA2; Glenn M. Chertow MD, MPH3; Jose Sanabria MD2; and Karen C. Lahive MD4

1 From the Pulmonary/Critical Care Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
2 From Microbiology Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
3 From Renal Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
4 From Harvard Community Health Plan, Boston, MA.

Walter J. O'Donnell, MD, FCCP, Department of Medicine, AUH Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA 15212; e-mail: wodonnel{at}aherf.edu

Study objectives: To determine the feasibility of repeat sputum induction in acute Pneumocystis carinii pneumonia (PCP) and to define the rate of clearance of P carinii cysts from the respiratory tract of HIV-seropositive patients with acute PCP.

Design: Prospective cohort evaluation.

Setting: University medical center.

Participants: Twenty-four HIV-seropositive subjects with acute PCP.

Measurements: Sputum induction for P carinii 2, 3, 4, and 6 weeks after initial diagnosis, and follow-up for 1 year.

Results: Eighty-eight percent of subjects had residual cysts at 2 weeks, 76% at 3 weeks, 29% at 4 weeks, and 24% at 6 weeks postdiagnosis. A prior AIDS-defining illness (p = 0.033) or prior PCP (p = 0.004) predicted relapse within 6 months, but persistent cysts at 3 weeks did not; 8 of 16 sputum-positive subjects and 1 of 5 sputum-negative subjects experienced a relapse within 6 months (p = 0.34). Secondary prophylaxis with trimethoprim-sulfamethoxazole was associated with a reduced risk of relapse.

Conclusions: Serial sputum induction coupled with direct fluorescent antibody staining is a feasible, noninvasive method of respiratory tract surveillance for the eradication of P carinii during and after acute PCP. Three-quarters of HIV-seropositive patients with acute PCP have persistent cysts in their lungs at the end of antimicrobial treatment, despite clinical recuperation, but only one quarter have residual cysts 6 weeks postdiagnosis. A prior AIDS-defining illness and prior PCP are positively associated, and subsequent trimethoprim-sulfamethoxazole prophylaxis is negatively associated, with relapse within 6 months, while persistent organisms at 3 weeks do not appear to be a significant predictor of relapse risk.

Key Words: HIV infection • Pneumocystis carinii pneumonia • sputum induction

Submitted on September 30, 1997
Accepted on June 30, 1998







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American College of Chest Physicians.